Holdings (Monthly)
Guide ↗
Select Biotechnology Portfolio
· Fidelity Select Portfolios| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | ABBVIE INC | 00287Y109 | Feb 2026 | 3,049,432 | $707.7M | 13.22% | EC |
| 2 | KRYSTAL BIOTECH INC | 501147102 | Feb 2026 | 1,806,522 | $497.9M | 9.30% | EC |
| 3 | GILEAD SCIENCES INC | 375558103 | Feb 2026 | 3,149,952 | $469.2M | 8.77% | EC |
| 4 | AMGEN INC | 031162100 | Feb 2026 | 1,149,551 | $446.2M | 8.34% | EC |
| 5 | ALNYLAM PHARMACEUTICALS INC | 02043Q107 | Feb 2026 | 496,683 | $165.4M | 3.09% | EC |
| 6 | Fidelity Revere Street Trust | 31635A303 | Feb 2026 | 136,216,589 | $136.2M | 2.55% | STIV |
| 7 | PRAXIS PRECISION MEDICINES INC. | 74006W207 | Feb 2026 | 390,500 | $131.5M | 2.46% | EC |
| 8 | ASCENDIS PHARMA A/S | 04351P101 | Feb 2026 | 558,201 | $130.3M | 2.44% | EC |
| 9 | INSMED INC | 457669307 | Feb 2026 | 811,101 | $121.1M | 2.26% | EC |
| 10 | UCB SA | N/A | Feb 2026 | 390,274 | $116.3M | 2.17% | EC |
| 11 | ARGENX SE | 04016X101 | Feb 2026 | 149,344 | $114.5M | 2.14% | EC |
| 12 | REGENERON PHARMACEUTICALS INC | 75886F107 | Feb 2026 | 101,316 | $79.2M | 1.48% | EC |
| 13 | MODERNA INC | 60770K107 | Feb 2026 | 1,432,529 | $76.7M | 1.43% | EC |
| 14 | SCHOLAR ROCK HOLDING CORP | 80706P103 | Feb 2026 | 1,650,449 | $73.1M | 1.37% | EC |
| 15 | NATERA INC | 632307104 | Feb 2026 | 331,532 | $69.0M | 1.29% | EC |
| 16 | COGENT BIOSCIENCES INC | 19240Q201 | Feb 2026 | 1,691,394 | $65.7M | 1.23% | EC |
| 17 | CENTESSA PHARMACEUTICALS PLC | 152309100 | Feb 2026 | 2,187,494 | $58.8M | 1.10% | EC |
| 18 | BIOGEN INC | 09062X103 | Feb 2026 | 299,435 | $57.4M | 1.07% | EC |
| 19 | ROIVANT SCIENCES LTD | N/A | Feb 2026 | 1,972,719 | $57.1M | 1.07% | EC |
| 20 | VERTEX PHARMACEUTICALS INC | 92532F100 | Feb 2026 | 112,900 | $56.1M | 1.05% | EC |
| 21 | BRIDGEBIO PHARMA INC | 10806X102 | Feb 2026 | 707,304 | $47.0M | 0.88% | EC |
| 22 | PROTAGONIST THERAPEUTICS INC | 74366E102 | Feb 2026 | 506,713 | $46.7M | 0.87% | EC |
| 23 | IMMUNOME INC | 45257U108 | Feb 2026 | 2,131,664 | $46.6M | 0.87% | EC |
| 24 | TERNS PHARMACEUTICALS INC | 880881107 | Feb 2026 | 1,079,186 | $45.5M | 0.85% | EC |
| 25 | REVOLUTION MEDICINES INC | 76155X100 | Feb 2026 | 438,772 | $44.8M | 0.84% | EC |
| 26 | KYMERA THERAPEUTICS INC | 501575104 | Feb 2026 | 462,441 | $42.2M | 0.79% | EC |
| 27 | IONIS PHARMACEUTICALS INC | 462222100 | Feb 2026 | 476,377 | $38.7M | 0.72% | EC |
| 28 | ARRIVENT BIOPHARMA INC | 04272N102 | Feb 2026 | 1,680,003 | $38.6M | 0.72% | EC |
| 29 | CRINETICS PHARMACEUTICALS INC | 22663K107 | Feb 2026 | 926,671 | $38.1M | 0.71% | EC |
| 30 | ABIVAX SA | 00370M103 | Feb 2026 | 301,600 | $36.6M | 0.68% | EC |
| 31 | STRUCTURE THERAPEUTICS INC | 86366E106 | Feb 2026 | 564,438 | $35.5M | 0.66% | EC |
| 32 | DISC MEDICINE INC | 254604101 | Feb 2026 | 532,174 | $35.5M | 0.66% | EC |
| 33 | GALDERMA GROUP AG | N/A | Feb 2026 | 184,660 | $34.8M | 0.65% | EC |
| 34 | ZEALAND PHARMA A/S | N/A | Feb 2026 | 589,130 | $33.9M | 0.63% | EC |
| 35 | CYTOKINETICS INC | 23282W605 | Feb 2026 | 503,175 | $31.3M | 0.59% | EC |
| 36 | CANDEL THERAPEUTICS INC | 137404109 | Feb 2026 | 5,911,951 | $31.0M | 0.58% | EC |
| 37 | VIRIDIAN THERAPEUTICS INC | 92790C104 | Feb 2026 | 1,001,204 | $29.4M | 0.55% | EC |
| 38 | VAXCYTE INC | 92243G108 | Feb 2026 | 470,455 | $29.0M | 0.54% | EC |
| 39 | STOKE THERAPEUTICS INC | 86150R107 | Feb 2026 | 792,594 | $28.9M | 0.54% | EC |
| 40 | NUVALENT INC | 670703107 | Feb 2026 | 273,399 | $27.9M | 0.52% | EC |
| 41 | APOGEE THERAPEUTICS INC | 03770N101 | Feb 2026 | 392,757 | $27.5M | 0.51% | EC |
| 42 | TREVI THERAPEUTICS INC | 89532M101 | Feb 2026 | 2,288,485 | $27.3M | 0.51% | EC |
| 43 | ANNEXON INC | 03589W102 | Feb 2026 | 4,733,596 | $26.5M | 0.50% | EC |
| 44 | ARROWHEAD PHARMACEUTICALS INC | 04280A100 | Feb 2026 | 409,378 | $25.9M | 0.48% | EC |
| 45 | DIANTHUS THERAPEUTICS INC | 252828108 | Feb 2026 | 432,218 | $23.9M | 0.45% | EC |
| 46 | VOR BIOPHARMA INC | 929033207 | Feb 2026 | 1,536,125 | $23.7M | 0.44% | EC |
| 47 | EDGEWISE THERAPEUTICS INC | 28036F105 | Feb 2026 | 776,925 | $23.6M | 0.44% | EC |
| 48 | UNITED THERAPEUTICS CORP DEL | 91307C102 | Feb 2026 | 44,593 | $22.5M | 0.42% | EC |
| 49 | INTELLIA THERAPEUTICS INC | 45826J105 | Feb 2026 | 1,607,833 | $22.2M | 0.41% | EC |
| 50 | TRAVERE THERAPEUTICS INC | 89422G107 | Feb 2026 | 720,343 | $21.5M | 0.40% | EC |
| 51 | DYNE THERAPEUTICS INC | 26818M108 | Feb 2026 | 1,368,144 | $21.4M | 0.40% | EC |
| 52 | BIO AB HOLDINGS LLC | N/A | Feb 2026 | 1,954,526 | $20.7M | 0.39% | EC |
| 53 | CORCEPT THERAPEUTICS INC | 218352102 | Feb 2026 | 575,646 | $20.6M | 0.38% | EC |
| 54 | IDEAYA BIOSCIENCES INC | 45166A102 | Feb 2026 | 637,957 | $20.5M | 0.38% | EC |
| 55 | MADRIGAL PHARMACEUTICALS INC | 558868105 | Feb 2026 | 47,495 | $20.5M | 0.38% | EC |
| 56 | NEWAMSTERDAM PHARMA COMPANY NV | N/A | Feb 2026 | 562,500 | $19.9M | 0.37% | EC |
| 57 | AMYLYX PHARMACEUTICALS INC | 03237H101 | Feb 2026 | 1,219,575 | $18.5M | 0.35% | EC |
| 58 | BIOHAVEN LTD | N/A | Feb 2026 | 1,603,096 | $18.5M | 0.35% | EC |
| 59 | SUMMIT THERAPEUTICS INC | 86627T108 | Feb 2026 | 1,089,169 | $18.1M | 0.34% | EC |
| 60 | SPYRE THERAPEUTICS INC | 00773J202 | Feb 2026 | 401,953 | $17.3M | 0.32% | EC |
| 61 | ARCUS BIOSCIENCES INC | 03969F109 | Feb 2026 | 831,100 | $16.9M | 0.32% | EC |
| 62 | OLEMA PHARMACEUTICALS INC | 68062P106 | Feb 2026 | 693,100 | $16.8M | 0.31% | EC |
| 63 | ALUMIS INC | 022307102 | Feb 2026 | 561,900 | $16.7M | 0.31% | EC |
| 64 | ORUKA THERAPEUTICS INC | 687604108 | Feb 2026 | 475,783 | $16.4M | 0.31% | EC |
| 65 | BICARA THERAPEUTICS INC | 055477103 | Feb 2026 | 944,900 | $15.9M | 0.30% | EC |
| 66 | AXSOME THERAPEUTICS INC | 05464T104 | Feb 2026 | 92,303 | $15.1M | 0.28% | EC |
| 67 | REPLIMUNE GROUP INC | 76029N106 | Feb 2026 | 1,864,545 | $14.3M | 0.27% | EC |
| 68 | MAZE THERAPEUTICS INC | 578784100 | Feb 2026 | 311,885 | $14.2M | 0.27% | EC |
| 69 | RAPPORT THERAPEUTICS INC | 75383L102 | Feb 2026 | 471,773 | $13.7M | 0.26% | EC |
| 70 | VIKING THERAPEUTICS INC | 92686J106 | Feb 2026 | 404,257 | $13.7M | 0.26% | EC |
| 71 | GALECTO INC | 36322Q206 | Feb 2026 | 454,559 | $13.4M | 0.25% | EC |
| 72 | BEONE MEDICINES LTD | 07725L102 | Feb 2026 | 41,698 | $13.2M | 0.25% | EC |
| 73 | XENON PHARMACEUTICALS INC | 98420N105 | Feb 2026 | 297,364 | $12.9M | 0.24% | EC |
| 74 | NUVATION BIO INC | 67080N101 | Feb 2026 | 2,164,933 | $12.8M | 0.24% | EC |
| 75 | MINERALYS THERAPEUTICS INC | 603170101 | Feb 2026 | 421,700 | $12.3M | 0.23% | EC |
| 76 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | N/A | Feb 2026 | 267,500 | $11.9M | 0.22% | EC |
| 77 | SOLID BIOSCIENCES INC | 83422E204 | Feb 2026 | 1,791,160 | $11.1M | 0.21% | EC |
| 78 | IDORSIA LTD | N/A | Feb 2026 | 2,174,283 | $11.1M | 0.21% | EC |
| 79 | GERON CORP | 374163103 | Feb 2026 | 6,492,512 | $10.9M | 0.20% | EC |
| 80 | ENLIVEN THERAPEUTICS INC | 29337E102 | Feb 2026 | 363,267 | $10.8M | 0.20% | EC |
| 81 | TECTONIC THERAPEUTIC INC | 878972108 | Feb 2026 | 442,889 | $10.4M | 0.19% | EC |
| 82 | IMMUNOCORE HOLDINGS PLC | 45258D105 | Feb 2026 | 321,500 | $10.4M | 0.19% | EC |
| 83 | UNIQURE N.V. | N/A | Feb 2026 | 650,282 | $10.2M | 0.19% | EC |
| 84 | ZENAS BIOPHARMA INC | 98937L105 | Feb 2026 | 380,400 | $10.0M | 0.19% | EC |
| 85 | VTV THERAPEUTICS INC | 918385204 | Feb 2026 | 260,391 | $9.9M | 0.19% | EC |
| 86 | BIONTECH SE | 09075V102 | Feb 2026 | 85,400 | $9.4M | 0.18% | EC |
| 87 | FORTE BIOSCIENCES INC | 34962G208 | Feb 2026 | 310,965 | $9.4M | 0.18% | EC |
| 88 | RHYTHM PHARMACEUTICALS INC | 76243J105 | Feb 2026 | 99,803 | $9.3M | 0.17% | EC |
| 89 | BIO AB HOLDINGS LLC | N/A | Feb 2026 | 1,954,526 | $9.2M | 0.17% | EC |
| 90 | PTC THERAPEUTICS INC | 69366J200 | Feb 2026 | 134,511 | $9.2M | 0.17% | EC |
| 91 | GUBRA A/S | N/A | Feb 2026 | 145,554 | $9.0M | 0.17% | EC |
| 92 | CAPRICOR THERAPEUTICS INC | 14070B309 | Feb 2026 | 314,700 | $8.8M | 0.16% | EC |
| 93 | TRIVENI BIO INC | N/A | Feb 2026 | 7,167,431 | $8.2M | 0.15% | EP |
| 94 | TWIST BIOSCIENCE CORP | 90184D100 | Feb 2026 | 170,825 | $8.0M | 0.15% | EC |
| 95 | SENSORION SA | N/A | Feb 2026 | 18,153,474 | $7.8M | 0.15% | EC |
| 96 | AKTIS ONCOLOGY INC | 01021M104 | Feb 2026 | 383,955 | $7.7M | 0.14% | EC |
| 97 | MANNKIND CORP | 56400P706 | Feb 2026 | 2,185,101 | $7.2M | 0.13% | EC |
| 98 | OCULAR THERAPEUTIX INC | 67576A100 | Feb 2026 | 784,000 | $7.0M | 0.13% | EC |
| 99 | BEAM THERAPEUTICS INC | 07373V105 | Feb 2026 | 244,914 | $7.0M | 0.13% | EC |
| 100 | ZENAS BIOPHARMA INC | N/A | Feb 2026 | 263,137 | $6.9M | 0.13% | EC |
| 101 | IMMUNOVANT INC | 45258J102 | Feb 2026 | 250,021 | $6.9M | 0.13% | EC |
| 102 | WAVE LIFE SCIENCES LTD | N/A | Feb 2026 | 487,140 | $6.8M | 0.13% | EC |
| 103 | CYTOMX THERAPEUTICS INC | 23284F105 | Feb 2026 | 1,222,540 | $6.6M | 0.12% | EC |
| 104 | TANGO THERAPEUTICS INC | 87583X109 | Feb 2026 | 586,000 | $6.5M | 0.12% | EC |
| 105 | IMMUNEERING CORP | 45254E107 | Feb 2026 | 1,290,698 | $6.4M | 0.12% | EC |
| 106 | DESIGN THERAPEUTICS INC | 25056L103 | Feb 2026 | 616,831 | $6.4M | 0.12% | EC |
| 107 | NURIX THERAPEUTICS INC | 67080M103 | Feb 2026 | 396,646 | $6.3M | 0.12% | EC |
| 108 | CAMP4 THERAPEUTICS CORP | 13463J101 | Feb 2026 | 1,326,208 | $6.0M | 0.11% | EC |
| 109 | X4 PHARMACEUTICALS INC | 98420X202 | Feb 2026 | 1,685,700 | $5.8M | 0.11% | EC |
| 110 | PROTHENA CORP PLC | N/A | Feb 2026 | 643,917 | $5.6M | 0.10% | EC |
| 111 | CAMP4 THERAPEUTICS CORP | N/A | Feb 2026 | 1,226,606 | $5.5M | 0.10% | EC |
| 112 | CARDURION PHARMACEUTICALS INC | N/A | Feb 2026 | 1,020,908 | $5.4M | 0.10% | EP |
| 113 | ALECTOR INC | 014442107 | Feb 2026 | 2,221,104 | $5.4M | 0.10% | EC |
| 114 | LB PHARMACEUTICALS INC | 50180M108 | Feb 2026 | 221,731 | $5.3M | 0.10% | EC |
| 115 | SANA BIOTECHNOLOGY INC | 799566104 | Feb 2026 | 1,263,152 | $5.3M | 0.10% | EC |
| 116 | Fidelity Revere Street Trust | 31635A105 | Feb 2026 | 4,866,721 | $4.9M | 0.09% | STIV |
| 117 | JAZZ PHARMACEUTICALS PLC | N/A | Feb 2026 | 25,600 | $4.9M | 0.09% | EC |
| 118 | JADE BIOSCIENCES INC | 008064206 | Feb 2026 | 321,707 | $4.8M | 0.09% | EC |
| 119 | VERA THERAPEUTICS INC | 92337R101 | Feb 2026 | 109,013 | $4.4M | 0.08% | EC |
| 120 | HANSA BIOPHARMA AB | N/A | Feb 2026 | 1,176,800 | $4.4M | 0.08% | EC |
| 121 | DENALI THERAPEUTICS INC | 24823R105 | Feb 2026 | 205,263 | $4.3M | 0.08% | EC |
| 122 | TAYSHA GENE THERAPIES INC | 877619106 | Feb 2026 | 940,476 | $4.3M | 0.08% | EC |
| 123 | SCORPION THERAPEUTICS INC | N/A | Feb 2026 | 5,166,448 | $4.2M | 0.08% | EC |
| 124 | ABSCI CORP | 00091E109 | Feb 2026 | 1,540,796 | $4.2M | 0.08% | EC |
| 125 | EIKON THERAPEUTICS INC | 282564103 | Feb 2026 | 305,088 | $4.2M | 0.08% | EC |
| 126 | PHARVARIS BV | N/A | Feb 2026 | 147,914 | $4.2M | 0.08% | EC |
| 127 | ALLOGENE THERAPEUTICS INC | 019770106 | Feb 2026 | 1,401,115 | $3.9M | 0.07% | EC |
| 128 | NEURONA THERAPEUTICS INC | N/A | Feb 2026 | 1,618,100 | $3.8M | 0.07% | EP |
| 129 | FOGHORN THERAPEUTICS INC | 344174107 | Feb 2026 | 654,278 | $3.7M | 0.07% | EC |
| 130 | SOLENO THERAPEUTICS INC | 834203309 | Feb 2026 | 87,300 | $3.4M | 0.06% | EC |
| 131 | ZURA BIO LTD | N/A | Feb 2026 | 509,657 | $3.4M | 0.06% | EC |
| 132 | BIO TUB HOLDINGS LLC | N/A | Feb 2026 | 9,200 | $3.3M | 0.06% | EC |
| 133 | ARS PHARMACEUTICALS INC | 82835W108 | Feb 2026 | 335,156 | $3.1M | 0.06% | EC |
| 134 | PARABILIS MEDICINES INC | N/A | Feb 2026 | 491,600 | $3.0M | 0.06% | EP |
| 135 | NATIONAL RESILIENCE INC | N/A | Feb 2026 | 732,064 | $2.9M | 0.05% | EP |
| 136 | JANUX THERAPEUTICS INC | 47103J105 | Feb 2026 | 206,670 | $2.8M | 0.05% | EC |
| 137 | CARTESIAN THERAPEUTICS INC | 816212302 | Feb 2026 | 366,554 | $2.8M | 0.05% | EC |
| 138 | ORUKA THERAPEUTICS INC | N/A | Feb 2026 | 76,300 | $2.6M | 0.05% | EC |
| 139 | MOONLAKE IMMUNOTHERAPEUTICS | 61559X104 | Feb 2026 | 143,558 | $2.5M | 0.05% | EC |
| 140 | BRIDGEBIO ONCOLOGY THERAPEUTIC | 107924102 | Feb 2026 | 240,300 | $2.4M | 0.05% | EC |
| 141 | ENGENE HOLDINGS INC | 29286M105 | Feb 2026 | 232,200 | $2.3M | 0.04% | EC |
| 142 | PALVELLA THERAPEUTICS INC | 697947109 | Feb 2026 | 16,700 | $2.3M | 0.04% | EC |
| 143 | CANDID THERAPEUTICS | N/A | Feb 2026 | 1,666,667 | $2.0M | 0.04% | EP |
| 144 | KARDIGAN INC | N/A | Feb 2026 | 93,611 | $2.0M | 0.04% | EP |
| 145 | TG THERAPEUTICS INC | 88322Q108 | Feb 2026 | 66,231 | $2.0M | 0.04% | EC |
| 146 | MIRUM PHARMACEUTICALS INC | 604749101 | Feb 2026 | 20,400 | $1.9M | 0.04% | EC |
| 147 | CRESCENT BIOPHARMA INC | N/A | Feb 2026 | 149,142 | $1.8M | 0.03% | EC |
| 148 | UPSTREAM BIO INC | 91678A107 | Feb 2026 | 234,657 | $1.8M | 0.03% | EC |
| 149 | EXELIXIS INC | 30161Q104 | Feb 2026 | 40,610 | $1.8M | 0.03% | EC |
| 150 | SCORPION THERAPEUTICS INC | N/A | Feb 2026 | 5,166,448 | $1.8M | 0.03% | EC |
| 151 | ATYR PHARMA INC | 002120202 | Feb 2026 | 1,754,594 | $1.7M | 0.03% | EC |
| 152 | CARTESIAN THERAPEUTICS INC | 816212112 | Feb 2026 | 5,385,728 | $1.6M | 0.03% | EC |
| 153 | SHATTUCK LABS INC | 82024L103 | Feb 2026 | 391,662 | $1.5M | 0.03% | EC |
| 154 | PERSPECTIVE THERAPEUTICS INC | 46489V302 | Feb 2026 | 258,600 | $1.4M | 0.03% | EC |
| 155 | GH RESEARCH PLC | N/A | Feb 2026 | 92,500 | $1.4M | 0.03% | EC |
| 156 | CRESCENT BIOPHARMA INC | N/A | Feb 2026 | 113,421 | $1.4M | 0.03% | EC |
| 157 | CG ONCOLOGY INC | 156944100 | Feb 2026 | 22,628 | $1.3M | 0.02% | EC |
| 158 | ANAPTYSBIO INC | 032724106 | Feb 2026 | 23,300 | $1.3M | 0.02% | EC |
| 159 | NEUROGENE INC | 64135M105 | Feb 2026 | 51,100 | $1.2M | 0.02% | EC |
| 160 | DAY ONE BIOPHARMACEUTICALS INC | 23954D109 | Feb 2026 | 108,347 | $1.1M | 0.02% | EC |
| 161 | ATEA PHARMACEUTICALS INC | 04683R106 | Feb 2026 | 237,534 | $1.1M | 0.02% | EC |
| 162 | VERADERMICS INC | 922967104 | Feb 2026 | 20,800 | $954K | 0.02% | EC |
| 163 | LEXICON PHARMACEUTICALS INC | 528872302 | Feb 2026 | 515,300 | $757K | 0.01% | EC |
| 164 | LEGEND BIOTECH CORP | 52490G102 | Feb 2026 | 32,710 | $621K | 0.01% | EC |
| 165 | BIOMEA FUSION INC | 09077A106 | Feb 2026 | 452,663 | $620K | 0.01% | EC |
| 166 | ERASCA INC | 29479A108 | Feb 2026 | 39,880 | $545K | 0.01% | EC |
| 167 | LENZ THERAPEUTICS INC | 52635N103 | Feb 2026 | 38,058 | $513K | 0.01% | EC |
| 168 | HARMONY BIOSCIENCES HOLDINGS INC | 413197104 | Feb 2026 | 17,525 | $500K | 0.01% | EC |
| 169 | APELLIS PHARMACEUTICALS INC | 03753U106 | Feb 2026 | 23,822 | $499K | 0.01% | EC |
| 170 | ELEVATEBIO, LLC | N/A | Feb 2026 | 216,600 | $440K | 0.01% | EP |
| 171 | KORRO BIO INC | N/A | Feb 2026 | 32,866 | $399K | 0.01% | EC |
| 172 | TARSUS PHARMACEUTICALS INC | 87650L103 | Feb 2026 | 4,800 | $362K | 0.01% | EC |
| 173 | KEROS THERAPEUTICS INC | 492327101 | Feb 2026 | 24,578 | $349K | 0.01% | EC |
| 174 | BIOCRYST PHARMACEUTICALS INC | 09058V103 | Feb 2026 | 37,881 | $331K | 0.01% | EC |
| 175 | ANTARES THERAPEUTICS INC | N/A | Feb 2026 | 325,500 | $267K | 0.00% | EC |
| 176 | ENTRADA THERAPEUTICS INC | 29384C108 | Feb 2026 | 14,169 | $169K | 0.00% | EC |
| 177 | NOVOCURE LTD | N/A | Feb 2026 | 11,113 | $152K | 0.00% | EC |
| 178 | FOGHORN THERAPEUTICS INC | N/A | Feb 2026 | 372,579 | $151K | 0.00% | EC |
| 179 | BIOXCEL THERAPEUTICS INC | 09075P204 | Feb 2026 | 90,300 | $151K | 0.00% | EC |
| 180 | INHIBIKASE THERAPEUTICS INC | 45719W205 | Feb 2026 | 56,270 | $115K | 0.00% | EC |
| 181 | BLUE MARLIN THERAPEUTICS, INC. | N/A | Feb 2026 | 1,636 | $102K | 0.00% | EC |
| 182 | ULTRAGENYX PHARMACEUTICAL INC | 90400D108 | Feb 2026 | 3,489 | $82K | 0.00% | EC |
| 183 | FOGHORN THERAPEUTICS INC | N/A | Feb 2026 | 372,579 | $32K | 0.00% | EC |
| 184 | CYCLERION THERAPEUTICS INC | N/A | Feb 2026 | 4,740 | $6K | 0.00% | EC |
| 185 | BIOMEA FUSION INC | N/A | Feb 2026 | 46,134 | $2K | 0.00% | EC |
| 186 | AFFERENT PHARMA | N/A | Feb 2026 | 8,274,568 | $83 | 0.00% | EP |
| 187 | SCORPION THERAPEUTICS INC | N/A | Feb 2026 | 5,166,448 | $52 | 0.00% | EC |
| 188 | CHINOOK THERAPEUTICS INC | N/A | Feb 2026 | 115,821 | $1 | 0.00% | EC |
| 189 | OPTINOSE INC | 68404V118 | Feb 2026 | 91,712 | $1 | 0.00% | EC |
| 190 | AXCELLA HEALTH INC | 05454B204 | Feb 2026 | 66,454 | $1 | 0.00% | EC |
| 191 | MEDAVAIL HOLDINGS INC | N/A | Feb 2026 | 55 | $0 | 0.00% | EC |